Brought to you by:
VQI analysis highlights impact of PAD on dialysis access outcomes
Peripheral artery disease (PAD) is a strong predictor of poor outcomes after hemodialysis access creation, according to a recent study led by Mahmoud Malas, MD, using data from the Vascular Quality Initiative (VQI). Vascular Specialist spoke with Malas about the…
Beyond the procedure: Rethinking long-term AVF success with VasQ
This advertorial is sponsored by Laminate Medical. What happens after a fistula is created can be just as important as the procedure itself. Dion Franga, MD, shares how innovations like VasQ may help improve fistula maturation, reduce catheter time and…
The thrill is gone: Preserving dialysis access
I can feel Brian’s presence hovering over me before he speaks and I know what’s coming. He’s fielded a call from a dialysis patient we take care of and there’s an issue with their fistula. It may be high pressures,…
Merit Medical announces FDA approval of the Wrapsody cell-impermeable endoprosthesis
Merit Medical Systems announced today that the Wrapsody cell-impermeable endoprosthesis has received premarket approval from the US Food and Drug Administration (FDA). With this approval, a press release notes, Merit can begin commercialisation of the device in the USA in…
Gore acquires InnAVasc Medical
Gore has announced the acquisition of InnAVasc Medical, a privately held medical technology company focused on advancing care for patients with end-stage renal disease who utilise graft circuits for dialysis treatment. Jeffrey Lawson, MD, PhD, and Shawn Gage, PA-C, of…
OBL: Keys to success in the outpatient setting
The ability to pivot in the face of changes to reimbursement while still meeting the needs of patients is a key facet of success in the office-based lab (OBL). That was among the key messages delivered by Brian DeRubertis, MD,…